{"name":"Philips","slug":"philips","ticker":"PHG","exchange":"NYSE","domain":"philips.com","description":"Koninklijke Philips N.V., simply branded Philips, is a Dutch multinational health technology and former consumer electronics company that was founded in Eindhoven in 1891. Since 1997, its world headquarters have been situated in Amsterdam, though the Benelux headquarters is still in Eindhoven. The company gained its royal honorary title in 1998.","hq":"Amsterdam, Netherlands","founded":1891,"employees":"64317","ceo":"Roy Jakobs","sector":"Health Technology","stockPrice":25.61,"stockChange":-0.02,"stockChangePercent":-0.08,"marketCap":"$28.5B","metrics":{"revenue":20607405416.145714,"revenueGrowth":-4.7,"grossMargin":45.2,"rdSpend":0,"netIncome":1130708990.3999999,"cash":3027683577.6,"dividendYield":3.95,"peRatio":21.7,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-01","type":"earnings","headline":"Philips Reports Q4 2022 Earnings","summary":"Philips reported Q4 2022 earnings, with revenue of €4.9 billion and adjusted EBITA of €1.1 billion.","drugName":"","sentiment":"neutral"},{"date":"2022-09-01","type":"deal","headline":"Philips to Acquire Capsule Technologies","summary":"Philips announced the acquisition of Capsule Technologies, a provider of healthcare technology and services.","drugName":"","sentiment":"positive"},{"date":"2022-06-01","type":"regulatory","headline":"Philips Receives FDA Clearance for New MRI System","summary":"Philips received FDA clearance for its new MRI system, which features advanced imaging capabilities.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE53Ulc0MVRkanRrTk40aHM3OVZvMGVnbjZsNlBIdldiTGhNSW50Q2Vkel9nbVlTWks5SWVvSUMxTVM5YTR5a0FuMDV5WEhQSnRUUG1pTTZYbmJUcWhaSS1yaFZMZG5kZmxBaU5oUkZn?oc=5","date":"2026-03-05","type":"deal","source":"Morningstar","summary":"The Best Healthcare Stocks to Buy - Morningstar","headline":"The Best Healthcare Stocks to Buy","sentiment":"neutral"},{"date":"2026-02-19","type":"earnings","source":"SEC EDGAR","summary":"20-F filed with SEC: 20-F","headline":"Annual Report (20-F) Filed","sentiment":"neutral"},{"date":"2026-02-19","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"date":"2026-02-10","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"date":"2026-02-10","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPVWN5dmh3cnNaek96aXVha044YVNNWVU0UEkyeExTNEpzbXFtZzUzeGRFaFZvUmxaM0dqcDNfZ1pzaHdPa0xLNWZZdjk1WjNrVnZpR0h3REl6eXhqZXJaRUhYaEcxOVNtMWtHQkt2U2RvN0pTSzUwNmJwUF9sVXhsdUNaWjhnaG13LVdUaWdLbDAxVU9xNUlRUW9uNDBDREFzOURBMlFhVGFSSjhYU1dB?oc=5","date":"2025-11-04","type":"earnings","source":"Reuters","summary":"Philips profit boosted by launch of AI tools, tariff mitigation - Reuters","headline":"Philips profit boosted by launch of AI tools, tariff mitigation","sentiment":"neutral"},{"date":"2025-11-04","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOZXk1Q2hZZ3pibnd1MVkya3d3M0d1V0h1aEtLYWVIbzVOYWJrcEFrcmRueEVyekpaSmJDUHk0NHlpSUJ5bTE0VXVfWEt1bXVSZGo2RV8yajBRVHd2U2E0dGhaRkpZOE9uQlZkN2JPRFUyMmFGc2wySnhnckMtMERFME0wMTQ2SnE3VTgySlNMNS05ZXFqelJTaDk1bTc4WktGck9LdjBQNFBFWEFvZ2hfTHcwVlpkanpTZ0d3RWhhZUtjYUU4M0FRYkROR25rLWMzdDlKRlRWTG1DVGxJSU1TNA?oc=5","date":"2025-10-28","type":"regulatory","source":"Reuters","summary":"US FDA flags quality issues at three Philips' facilities - Reuters","headline":"US FDA flags quality issues at three Philips' facilities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNSVg1MVZGejBRTTU4T1NibWhSb3k1Q190M0ZDeTlGczV2aF9rSW8xR2dYQjVkdUhLU0pUdWxXQUVIcEZUb0FNWWNERUJIY01hQnd5XzQtV3dHbzhIQnFKanBPOGNFclRvdFAwcFYxU3RIQnF6MElLRW92MlNMajFRN0hnSmtSeTI3VGRReFFYUlppMXFVSnItRGxvZm1WRVhGLVVwQlUtZjM0OE1qel9yNEtndmFFOHlZajF5Nzh1aG0zN1M4SXlENkM3Nk4?oc=5","date":"2025-09-25","type":"pipeline","source":"Reuters","summary":"Philips in talks with US over probes of medical technology imports - Reuters","headline":"Philips in talks with US over probes of medical technology imports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNMExBR0ozWlVGTW1pN1dTeG1iUzhEdW9mbTFoU0dOblJPRy1sV29mNG85cEstNG1nUWU0LXJPRm1YY3JTcEt2WHBTZXNKMmZrSjF4aDloUGE5Mnd0VU85dmtFQk9KZjZnWUxxaHhDQ0pyZFNEZ2JpM0FrNjZSM2RMazlKYzRsVFJOWDBYSV9vZlRJLWVyeTVKTEJxemtlQVVxVnNLdXdmdmtVUzBEWTJOUV9lN1ktd0ltVUdQM1c1SjIyTnFZNlJoNkJnMzBuemtVVkJLX3lraUc?oc=5","date":"2025-07-29","type":"deal","source":"Reuters","summary":"Philips cuts tariff impact estimate following US-EU deal, shares up 10% - Reuters","headline":"Philips cuts tariff impact estimate following US-EU deal, shares up 10%","sentiment":"neutral"},{"date":"2025-07-29","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"date":"2025-06-05","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"},{"date":"2025-06-04","type":"earnings","source":"SEC EDGAR","summary":"6-K filed with SEC: 6-K","headline":"6-K Filing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Siemens Healthineers","GE Healthcare","Medtronic"],"therapeuticFocus":["Diagnostic Imaging","Patient Monitoring","Healthcare Informatics"],"financials":{"source":"sec_edgar+yahoo","revenue":20831677825.199997,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":20831677825.199997},{"period":"2024-12-31","value":21050110243.8},{"period":"2023-12-31","value":21222987238.199997},{"period":"2022-12-31","value":20823501210.6}],"grossProfit":9412451492.4,"grossProfitHistory":[{"period":"2025-12-31","value":9412451492.4},{"period":"2024-12-31","value":9079546469.4},{"period":"2023-12-31","value":8699917934.4},{"period":"2022-12-31","value":8403223633.199999}],"rdSpend":1985749259.9999998,"rdSpendHistory":[{"period":"2025-12-31","value":1985749259.9999998},{"period":"2024-12-31","value":2040649386.6},{"period":"2023-12-31","value":2207685942},{"period":"2022-12-31","value":2442471589.7999997}],"sgaSpend":5805396365.999999,"operatingIncome":1692559222.1999998,"operatingIncomeHistory":[{"period":"2025-12-31","value":1692559222.1999998},{"period":"2024-12-31","value":599229041.4},{"period":"2023-12-31","value":-196238750.39999998},{"period":"2022-12-31","value":-206751540.6}],"netIncome":1045438580.9999999,"netIncomeHistory":[{"period":"2025-12-31","value":1045438580.9999999},{"period":"2024-12-31","value":-819997635.5999999},{"period":"2023-12-31","value":-544328914.8},{"period":"2022-12-31","value":-1878285182.3999999}],"eps":0.94,"epsHistory":[{"period":"2025-12-31","value":0.94},{"period":"2024-12-31","value":-0.75},{"period":"2023-12-31","value":-0.493151},{"period":"2022-12-31","value":-1.684633}],"cash":3263637313.2,"cashHistory":[{"period":"2025-12-31","value":3263637313.2},{"period":"2024-12-31","value":2804578807.7999997},{"period":"2023-12-31","value":2183156098.2},{"period":"2022-12-31","value":1368998901.6}],"totalAssets":31472957683.199997,"totalLiabilities":18636840849,"totalDebt":9123933805.8,"equity":12798738024.599998,"operatingCashflow":1368998901.6,"operatingCashflowHistory":[{"period":"2025-12-31","value":1368998901.6},{"period":"2024-12-31","value":1832729758.1999998},{"period":"2023-12-31","value":2495035540.7999997},{"period":"2022-12-31","value":-202079189.39999998}],"capex":-780282650.4,"capexHistory":[{"period":"2025-12-31","value":-780282650.4},{"period":"2024-12-31","value":-789627352.8},{"period":"2023-12-31","value":-752248543.1999999},{"period":"2022-12-31","value":-941478766.8}],"freeCashflow":588716251.1999999,"dividendsPaid":-383132798.4,"buybacks":0,"employees":64317,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":1524354578.9999998,"ebit":609741831.5999999,"ebitda":934470239.9999999,"period":"2025-12-31","revenue":5954911604.4,"epsBasic":0.42,"netIncome":461394680.99999994,"rdExpense":498773490.59999996,"epsDiluted":0.42,"grossProfit":2672584886.3999996,"operatingIncome":659969607},{"sga":1376007428.3999999,"ebit":412334993.4,"ebitda":766265596.8,"period":"2025-09-30","revenue":5025113715.599999,"epsBasic":0.19,"netIncome":214928155.2,"rdExpense":483588349.1999999,"epsDiluted":0.19,"grossProfit":2232215785.7999997,"operatingIncome":385468973.99999994},{"sga":1447260784.1999998,"ebit":487092612.59999996,"ebitda":797803967.4,"period":"2025-06-30","revenue":5067164876.4,"epsBasic":0.25,"netIncome":280341072,"rdExpense":469571295.59999996,"epsDiluted":0.25,"grossProfit":2349024565.7999997,"operatingIncome":468403207.79999995},{"sga":1457773574.3999999,"ebit":217264330.79999998,"ebitda":539656563.5999999,"period":"2025-03-31","revenue":4785655716.599999,"epsBasic":0.08,"netIncome":88774672.8,"rdExpense":533816124.59999996,"epsDiluted":0.08,"grossProfit":2159794342.2,"operatingIncome":181053608.99999997},{"sga":1547716334.9999998,"ebit":200911101.6,"ebitda":200911101.6,"period":"2024-12-31","revenue":5891834863.2,"epsBasic":-0.36,"netIncome":-391309412.99999994,"rdExpense":551337441.5999999,"epsDiluted":-0.36,"grossProfit":2292956351.3999996,"operatingIncome":213760067.39999998}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":25.61,"previousClose":25.63,"fiftyTwoWeekHigh":33.44,"fiftyTwoWeekLow":21.95,"fiftyTwoWeekRange":"21.95 - 33.44","fiftyDayAverage":27.68,"twoHundredDayAverage":28.11,"beta":0.92,"enterpriseValue":34962294079.85909,"forwardPE":12.5,"priceToBook":1.82,"priceToSales":1.38,"enterpriseToRevenue":1.7,"enterpriseToEbitda":14.31,"pegRatio":0,"ebitda":2442471664.557619,"ebitdaMargin":11.9,"freeCashflow":1773303356.7879167,"operatingCashflow":2678425250.6423807,"totalDebt":9458006841.84238,"debtToEquity":70.9,"currentRatio":1.32,"returnOnAssets":3.5,"returnOnEquity":8.4,"analystRating":"2.6 - Hold","recommendationKey":"hold","numberOfAnalysts":5,"targetMeanPrice":33.84,"targetHighPrice":41,"targetLowPrice":29.2,"dividendRate":1.01,"payoutRatio":0.85,"fiveYearAvgDividendYield":2.64,"exDividendDate":1778630400,"insiderHeldPercent":0,"institutionHeldPercent":5.4,"sharesOutstanding":952018000,"floatShares":950694695,"sharesShort":2025224,"shortRatio":1.76,"shortPercentOfFloat":0.2,"epsTrailing":1.18,"epsForward":2.05,"revenuePerShare":18.57,"bookValue":14.09,"officers":[{"age":51,"name":"Mr. Roy W. O. Jakobs","title":"President, CEO & Chairman of the Board of Management"},{"age":63,"name":"Dr. Paulus A. Stoffels M.D., Ph.D.","title":"Independent Vice Chairman of Supervisory Board & Secretary"},{"age":47,"name":"Ms. Charlotte  Hanneman","title":"Executive VP, CFO & Member of Board of Management"},{"age":52,"name":"Mr. Marnix J. van Ginneken Ph.D.","title":"Executive VP, Chief ESG & Legal Officer and Member of the Board of Management"},{"age":61,"name":"Mr. Willem  Appelo","title":"Executive VP & COO"},{"age":null,"name":"Ms. Durga  Doraisamy","title":"Head of Investor Relations"},{"age":51,"name":"Ms. Heidi  Sichien","title":"Executive VP & Chief People Officer"},{"age":67,"name":"Dr. Jan  Kimpen M.D., Ph.D.","title":"Chief Medical Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.philips.com","phone":"31 20 597 7777"}}